GlassScriptPhysician profile
Julio C Gonzalez
NPI 1588762082
$995.54
in general payments reported to CMS, 2019-2025
17 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.60 · 2020: $26.66 · 2021: $176 · 2022: $135 · 2023: $267 · 2024: $186 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $263.18 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Kowa Pharmaceuticals America, INC. | $149.05 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.98 | 2022-2023 | |
| Abbvie INC. | $62.61 | 2023-2025 | |
| Janssen Biotech, INC. | $60.62 | 2024-2025 | Tremfya |
| Janssen Pharmaceuticals, INC | $55.50 | 2019-2021 | |
| Exact Sciences Corporation | $47.31 | 2023 | Cologuard Collection Kit |
| Saluda Medical Americas, INC. | $38.75 | 2025 | Evoke |
| Mallinckrodt Enterprises LLC | $38.06 | 2019 | |
| Dexcom, INC. | $32.62 | 2021-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $24.30 | 2025 | Gemtesa |
| Orexo US, INC. | $23.60 | 2023 | Zubsolv |
| Organon LLC | $22.35 | 2023 | Nexplanon |
| Allergan, INC. | $18.95 | 2019 | |
| Evoke Pharma, INC. | $14.64 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.45 | 2024 | Tepezza |
| Amarin Pharma, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.